<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="701">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04377789</url>
  </required_header>
  <id_info>
    <org_study_id>KSSEAH--0058</org_study_id>
    <nct_id>NCT04377789</nct_id>
  </id_info>
  <brief_title>Effect of Quercetin on Prophylaxis and Treatment of COVID-19</brief_title>
  <official_title>The Possible Effect of Quercetin on Prophylaxis and Treatment of COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kanuni Sultan Suleyman Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kanuni Sultan Suleyman Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Novel Coronavirus is defined to be the cause of COVID-19, recently. It's known that COVID-19
      goes with excessive immune reaction of human body in severe cases. The investigators
      hypothesize that quercetin, as a strong scavenger and anti-inflammatory agent, can be
      effective on both prophylaxis and treatment of COVID-19 cases. Therefore, the aim of this
      study to evaluate the possible role of quercetin on prophylaxis and treatment of COVID-19.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Novel Coronavirus is defined to be the cause of COVID-19, recently. It's known that COVID-19
      goes with excessive immune reaction of human body in severe cases. Quercetin is reported to
      be effective on treatment and prophylaxis of other SARS like coronavirus infections, as a
      strong antioxidant and scavenger flavonoid without any adverse events. Upon this data, the
      investigators hypothesize that quercetin can be effective on both prophylaxis and treatment
      of COVID-19 cases. Therefore, the aim of this study to evaluate the possible role of
      quercetin on prophylaxis and treatment of COVID-19.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of COVID-19 calculated using a questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>Prevalence of COVID-19 in prophylaxis and sham group will be calculated using a questionnaire including hospital records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Standardized Mortality rate</measure>
    <time_frame>3 months</time_frame>
    <description>Mortality rate will be compared between two groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity rate</measure>
    <time_frame>3 months</time_frame>
    <description>Morbidity rates besides recovery rates from COVID-19 will be documented</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>non-quercetin group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants, who accept to enroll the study without having quercetin prophylaxis and who do not have a history of COVID-19, will be in this group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>quercetin prophylaxis group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants, who takes a daily dose of 500mg quercetin and who not have a history of COVID-19, will be in this group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>quercetin treatment group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants, who takes a daily dose of 1000mg quercetin and who are proven cases for COVID-19, will be in this group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Quercetin Prophylaxis</intervention_name>
    <description>a daily dose of quercetin (500mg) will be taken by non-COVID-19 intervention group 1</description>
    <arm_group_label>quercetin prophylaxis group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Quercetin Treatment</intervention_name>
    <description>a daily dose of quercetin (1000mg) will be taken by proven COVID-19 cases intervention group 2</description>
    <arm_group_label>quercetin treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  moderate-high risk for COVID-19

          -  obtained informed consent

        Exclusion Criteria:

          -  declined to participate

          -  genetic/chromosomal abnormalities

          -  any kind of sensitivity or allergy for quercetin

          -  history of previous hypersensitivity with quercetin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hasan Onal</last_name>
    <phone>+905325092988</phone>
    <email>hasanonal@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Seda Yilmaz Semerci</last_name>
    <phone>+905337180683</phone>
    <email>sedayilmazsemerci@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kanuni Sultan Suleyman Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34303</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hasan Onal</last_name>
      <phone>+905325092988</phone>
      <email>hasanonal@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 1, 2020</study_first_submitted>
  <study_first_submitted_qc>May 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2020</study_first_posted>
  <last_update_submitted>May 14, 2020</last_update_submitted>
  <last_update_submitted_qc>May 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kanuni Sultan Suleyman Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Hasan Onal</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Quercetin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

